Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Brainstorm Cell (NQ: BCLI )

3.650 USD UNCHANGED
Streaming Delayed Price Updated: 9:00 AM EDT, Apr 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 119
Open 3.650
Bid (Size) 3.600 (2)
Ask (Size) 3.650 (2)
Prev. Close 3.650
Today's Range 3.650 - 3.650
52wk Range 3.100 - 17.95
Shares Outstanding 19,111,326
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BrainStorm Announces Positive Topline Data in Phase 2 Study Evaluating NurOwn® as a Treatment for Progressive MS
NurOwn® was shown to be safe and well tolerated 
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. ("Brainstorm" or the "Company") (NASDAQ: BCLI). Such investors are advised to contact Robert S.... 
From PR Newswire

Performance

YTD
-19.60%
-19.60%
1 Month
-14.72%
-14.72%
3 Month
-21.17%
-21.17%
6 Month
-78.27%
-78.27%
1 Year
-34.00%
-34.00%

More News

Read More
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
From PR Newswire
Notable Wednesday Option Activity: BCLI, NVCR, AMSC
Tags Stocks
From Market News Video
BrainStorm to Present at SVB Leerink 10th Global Healthcare Conference
From PR Newswire
Why Is It Moving? Looking Into Why Brainstorm Cell's Stock is Trading Higher Today
Tags Market News BZI/WIIM Benzinga
From Benzinga
Tenax Therapeutics, Inc. Expands Board of Directors
From Business Wire News Releases
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tags APTO CASI PSTV
From Benzinga
BrainStorm Cell Stock Surges As NurOwn Aces Mid-Stage Multiple Sclerosis Study
Tags Market News multiple sclerosis Benzinga
From Benzinga
Thinking about buying stock in Dolphin Entertainment, Hall of Fame Resort & Entertainment, Aptose Biosciences, Cinedigm, or Brainstorm Cell Therapeutics?
From PR Newswire
Analysts Anticipate FDM Will Reach $64
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.